GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
大菲尼克斯社区临床肿瘤学计划
基本信息
- 批准号:3557650
- 负责人:
- 金额:$ 11.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-09-01 至 1998-05-31
- 项目状态:已结题
- 来源:
- 关键词:antineoplastics cancer prevention cancer registry /resource cancer rehabilitation /care chemoprevention clinical trials community health services cooperative study human subject human therapy evaluation neoplasm /cancer chemotherapy neoplasm /cancer education neoplasm /cancer radiation therapy neoplasm /cancer therapy oncology oncology nursing patient care primary care physician
项目摘要
The Greater Phoenix Community Clinical Oncology Program (GPCCOP) is a
consortium of five hospitals with 38 investigators led by Principal
Investigator David K. King, M.D. Dr. King and many of the investigators
have been associated with the CCOP since its initial planning stage in
1982.
The continuing long-term goals and specific aims of the GPCCOP include: 1)
increased clinical research activities; 2) access to additional clinical
trials; 3) further development of cancer control research initiatives and
patient accrual; 4) maintenance of quality data management; 3) pharmacy
resources to coordinate and manage drug distribution; 6) involvement of
primary care physicians in state-of-the-art cancer management and
education; and 7) continued development of data management systems to
support NCI evaluations.
GPCCOP's organizational structure requires the involvement of the Co-
Principal Investigators and hospital administrators from each of the
participating institutions in the planning and policy-making decisions of
the CCOP. The physicians, nurses and administrative staff have active
roles in guiding the GPCCOP toward attainment of its goals. This
experienced team has demonstrated their commitment and ability to accrue
patients to both therapeutic and cancer control protocols while
maintaining high levels of quality control and timely submissions.
GPCCOP's data management systems were recognized by SWOG in 1991 with the
Outstanding Achievement Award.
Additional investigators, specializing in medical and radiation oncology,
have been recruited to the GPCCOP to ensure the availability of total
patient care for the 3000 average new cancer patients seen each year.
GPCCOP has experienced a 33% increase in the daily radiation therapy
treatments at the facilities, and in 1993 a new outpatient center at
Thunderbird Samaritan Medical Center will open with a medical oncology
treatment facility and a Radiation Therapy Unit.
大凤凰城社区临床肿瘤学项目(GPCCOP)是
由五家医院组成的财团,由校长领导,有38名调查人员
调查员大卫·K·金、医学博士金博士和许多调查人员
自#年初步规划阶段以来,一直与CCOP联系在一起
1982年。
GPCCOP的持续长期目标和具体目标包括:1)
增加临床研究活动;2)获得更多临床
试验;3)进一步发展癌症控制研究倡议和
病人应计费用;4)维护质量数据管理;3)药房
协调和管理药品分销的资源;6)参与
初级保健医生在最先进的癌症管理和
教育;以及7)继续开发数据管理系统以
支持NCI评估。
GPCCOP的组织结构需要联合委员会的参与。
首席调查员和医院管理人员分别来自
参与规划和决策的机构
CCOP。医生、护士和行政人员都很活跃
在指导GPCCOP实现其目标方面的作用。这
经验丰富的团队已经证明了他们的承诺和能力
患者接受治疗和癌症控制方案,同时
保持高水平的质量控制和及时提交。
GPCCOP的数据管理系统于1991年获得SWOG认可
杰出成就奖。
更多的调查人员,专门从事医学和放射肿瘤学,
已被招募到GPCCOP,以确保提供总
为每年平均3000名新癌症患者提供患者护理。
GPCCOP的每日放射治疗增加了33%
在这些设施中进行治疗,并于1993年在
雷鸟撒玛利亚医疗中心将以内科肿瘤学开幕
治疗设施和一个放射治疗单位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID K KING其他文献
DAVID K KING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID K KING', 18)}}的其他基金
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
大菲尼克斯社区临床肿瘤学计划
- 批准号:
2088900 - 财政年份:1983
- 资助金额:
$ 11.4万 - 项目类别:
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
大菲尼克斯社区临床肿瘤学计划
- 批准号:
2088898 - 财政年份:1983
- 资助金额:
$ 11.4万 - 项目类别:
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
大菲尼克斯社区临床肿瘤学计划
- 批准号:
2653984 - 财政年份:1983
- 资助金额:
$ 11.4万 - 项目类别:
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
大菲尼克斯社区临床肿瘤学计划
- 批准号:
3557649 - 财政年份:1983
- 资助金额:
$ 11.4万 - 项目类别:
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
大菲尼克斯社区临床肿瘤学计划
- 批准号:
6171984 - 财政年份:1983
- 资助金额:
$ 11.4万 - 项目类别:
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
大菲尼克斯社区临床肿瘤学计划
- 批准号:
3557655 - 财政年份:1983
- 资助金额:
$ 11.4万 - 项目类别:
相似海外基金
Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador
制定 HPV 耻辱评估量表和减少耻辱干预措施,以改善萨尔瓦多的宫颈癌预防
- 批准号:
10844859 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10829054 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
- 批准号:
10763054 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE
主题 453:初级保健中预防癌症的完美医疗助手
- 批准号:
10931123 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
Co-creating a community engagement knowledge translation summit on improving cancer prevention and screening in Canada
共同创建社区参与知识翻译峰会,以改善加拿大的癌症预防和筛查
- 批准号:
480839 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
Miscellaneous Programs
PIECES – Towards Large-Scale Adaption and Tailored Implementation of Evidence-Based Primary Cancer Prevention Programmes in Europe and Beyond
部分内容 — 致力于在欧洲及其他地区大规模适应和定制实施循证初级癌症预防计划
- 批准号:
10079747 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
EU-Funded
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
乌干达宫颈癌预防游戏规则改变者的混合实施-有效性试验
- 批准号:
10718609 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
使用移动医疗研究交叉性和健康行为:对边缘化人群的概念模型和癌症预防干预措施的影响
- 批准号:
10746886 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别: